Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
| Form | Size | Price | $/mg | Stock | Updated |
|---|---|---|---|---|---|
| vial | 5mg | $30.00$25.00 | $5.00/mg | In stock | Jul 9 |
| vial | 10mg | $100.00$85.00 | $8.50/mg | In stock | Jul 9 |
Single-vial list prices — bulk or bundle orders may be lower. Verify at vendor before purchase.
| Lot / Report | Tested | Purity | Lab | Panels | Status | |
|---|---|---|---|---|---|---|
| OS-2026-3074 | Jun 2026 | 99.6% | Janoshik Analytical | — | Confirmed | View |
The FDA PCAC advisory committee meets July 23–24, 2026 to review nominations and make recommendations on compounding eligibility — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. BPC-157 is on the proposed list. If the FDA subsequently issues a final rule, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Disclosed Labs does not provide medical or legal advice.
Does Optima Supply sell BPC-157?
Yes — Optima Supply currently lists BPC-157 in 2 variants starting at $25.00 ($5.00/mg).
Is Optima Supply's BPC-157 third-party tested?
Yes — Disclosed Labs has indexed 8 Certificates of Analysis for Optima Supply's BPC-157, with the most recent showing 99.6% purity. Optima Supply holds an overall trust grade of B (80/100) across all 131 COAs on file.
What is Optima Supply's trust grade for BPC-157?
Optima Supply has an overall Disclosed Labs trust grade of B (80/100), computed from 131 COAs across all peptides. The most recent BPC-157 COA was issued by Janoshik Analytical.
Where is the cheapest BPC-157?
As of the latest data, Alpha Peptides offers BPC-157 at $2.60/mg — compare with Optima Supply's listing at $5.00/mg. See the full BPC-157 price comparison.
Is BPC-157 legal to buy?
BPC-157 is among the peptides under FDA review for the Category 1 (503A) bulk-substances list — removed from Category 2 in April 2026 but not yet on a finalized Category 1 list. The FDA PCAC committee meets July 23–24, 2026 to make recommendations on which peptides may be compounded, and under what conditions — the PCAC is advisory only, and the FDA would issue any final rule on a separate, later timeline. If a final rule is ultimately issued, a valid prescription from a licensed prescriber may be required for compounding access; timing is uncertain. Current sales are for research purposes only. Disclosed Labs does not provide medical or legal advice.
| BPC3001 | Apr 2026 | 99.7% | Janoshik Analytical | — | Confirmed | View |
| OPTIMAD6W8KP | Dec 2025 | — | Janoshik Analytical | — | Confirmed | View |
| OPTIMAR8D3K1 | Dec 2025 | — | Janoshik Analytical | — | Confirmed | View |
| HYDROQ5L7R8S | Nov 2025 | 99.6% | Janoshik Analytical | — | Confirmed | View |
| — | Nov 2025 | 99.1% | Janoshik Analytical | — | Confirmed | View |
| BPC157-6048 | Aug 2024 | — | Janoshik Analytical | Heavy metals | Unverified | View |
| BPC1003 | Jul 2024 | — | Janoshik Analytical | Endotoxin | Confirmed | View |